First-in-Human Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Conditions:   Breast Cancer;   Colorectal Cancer;   Ovarian Cancer;   Non Small Cell Lung Cancer;   Acral Lentiginous Melanoma Intervention:   Biological: ATRC-101 Sponsor:   Atreca, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials